Best L et al., 2000: Cochrane meta-analysis of 13 RCTs (1365 patients) of palliative chemotherapy versus supportive care in advanced colorectal cancer. It found a 35% relative reduction in risk of death, 16% absolute survival gain at 6 and 12 months, and median survival gain of 3.7 months.
palliative chemotherapy was associated with a 35% (95% CI 24% to 44%) reduction in the risk of death. This translates into an absolute improvement in survival of 16% at both 6 months and 12 months
Abstract (MAIN RESULTS)
Best L et al., 2000: Cochrane meta-analysis of 13 RCTs (1365 patients) of palliative chemotherapy versus supportive care in advanced colorectal cancer. It found a 35% relative reduction in risk of death, 16% absolute survival gain at 6 and 12 months, and median survival gain of 3.7 months. Funder: internal – none; external – NHS National Cancer Research & Development Programme, UK. Conflicts: 'None'. Drugs: 5-fluorouracil-based systemic regimens and regional (hepatic arterial) infusion; makers not named. Comparator: supportive care (with some control-arm crossover to chemotherapy). The reviewers note toxicity, symptom control and quality of life were 'inadequately assessed' and evidence quality 'poor'. PMC7025779. Study type: review.
